Haematological effects of aspirin.
D000230:Adenocarcinoma / Q000188:drug therapy; D000818:Animals; D001241:Aspirin / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000517:prevention & control; D051379:Mice; D009362:Neoplasm Metastasis / Q000517:prevention & control*; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D009360:Neoplastic Cells, Circulating / Q000517:prevention & control*; D012965:Sodium Chloride / Q000627:therapeutic use; D014859:Warfarin / Q000627:therapeutic use
D012965:Sodium Chloride; D014859:Warfarin; D006493:Heparin; D001241:Aspirin